TR200102265T2 - Anestezi düzenlemesi. - Google Patents

Anestezi düzenlemesi.

Info

Publication number
TR200102265T2
TR200102265T2 TR2001/02265T TR200102265T TR200102265T2 TR 200102265 T2 TR200102265 T2 TR 200102265T2 TR 2001/02265 T TR2001/02265 T TR 2001/02265T TR 200102265 T TR200102265 T TR 200102265T TR 200102265 T2 TR200102265 T2 TR 200102265T2
Authority
TR
Turkey
Prior art keywords
anesthetic
regulation
delta
medicament
derivatives
Prior art date
Application number
TR2001/02265T
Other languages
English (en)
Turkish (tr)
Inventor
John Douglas Pomfrett Christopher
Alkire Michael
Haier Richard
Fallon Jim
Original Assignee
The Victoria University Of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9902469.7A external-priority patent/GB9902469D0/en
Application filed by The Victoria University Of Manchester filed Critical The Victoria University Of Manchester
Publication of TR200102265T2 publication Critical patent/TR200102265T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2001/02265T 1999-02-05 2000-02-01 Anestezi düzenlemesi. TR200102265T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9902469.7A GB9902469D0 (en) 1999-02-05 1999-02-05 Brain metabolism
US12032699P 1999-02-17 1999-02-17
US15566199P 1999-09-24 1999-09-24

Publications (1)

Publication Number Publication Date
TR200102265T2 true TR200102265T2 (tr) 2001-12-21

Family

ID=27269636

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02265T TR200102265T2 (tr) 1999-02-05 2000-02-01 Anestezi düzenlemesi.

Country Status (15)

Country Link
EP (1) EP1148887A2 (xx)
JP (1) JP2002536337A (xx)
KR (1) KR20010101992A (xx)
CN (1) CN1346278A (xx)
AP (1) AP2001002245A0 (xx)
AU (1) AU2445900A (xx)
BR (1) BR0008046A (xx)
CA (1) CA2360124A1 (xx)
ID (1) ID30518A (xx)
IL (1) IL144572A0 (xx)
MX (1) MXPA01007949A (xx)
NO (1) NO20013795D0 (xx)
OA (1) OA11758A (xx)
TR (1) TR200102265T2 (xx)
WO (1) WO2000045832A2 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
KR20100056524A (ko) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 배합물 티모신 베타 4 및 델타 수면 유도 펩티드의 용도
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
CN108376559B (zh) * 2018-02-28 2020-10-16 复旦大学附属中山医院 乙醛脱氢酶2基因型在麻醉剂量计算中的应用
CN112535727A (zh) * 2020-12-24 2021-03-23 安域生物制药(杭州)有限公司 一种具有睡眠改善作用的短肽凝胶及其制备方法
CN112908454B (zh) * 2021-02-26 2023-08-29 西安交通大学口腔医院 一种智能保管麻醉剂的方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (de) * 1977-06-30 1983-01-31 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung.
CA1188989A (en) * 1981-05-21 1985-06-18 Richard R. Scherschlicht Nonapeptide for the treatment of drug withdrawal symptoms
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
RU2104717C1 (ru) * 1995-07-07 1998-02-20 Новокузнецкий государственный институт усовершенствования врачей Способ анестезии при операциях у больных с синдромом лериша

Also Published As

Publication number Publication date
NO20013795L (no) 2001-08-02
CN1346278A (zh) 2002-04-24
IL144572A0 (en) 2002-05-23
MXPA01007949A (es) 2003-06-04
OA11758A (en) 2005-07-19
JP2002536337A (ja) 2002-10-29
ID30518A (id) 2001-12-13
WO2000045832A2 (en) 2000-08-10
NO20013795D0 (no) 2001-08-02
KR20010101992A (ko) 2001-11-15
CA2360124A1 (en) 2000-08-10
AP2001002245A0 (en) 2001-09-30
BR0008046A (pt) 2001-11-06
AU2445900A (en) 2000-08-25
EP1148887A2 (en) 2001-10-31
WO2000045832A3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
GB0123381D0 (en) Factor
DE69917609D1 (de) Arzneimittel und deren verwendung
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
NZ512866A (en) A nutritional composition comprising at least one tolerogenic peptide, selected for its ability to induce oral tolerance, as an active ingredient
ATE206308T1 (de) Arzneizusammensetzungen enthaltend ein bakterizides permeabilität erhöhendes protein und ein tensid
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
DE60225118D1 (de) Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
ATE290015T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
DE69400435T2 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
BR0014378A (pt) Derivados de ácido indolil-3-glioxìlico tendo propriedades terapeuticamente valiosas
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
HK1068606A1 (en) Novel aminobenzoephenones
TR200101633T2 (tr) Farmasötik bileşim
BR0013353A (pt) Combinação de substância ativa com clonidina
DE19680768D2 (de) Pharmazeutische Kombinationspräparate enthaltend Erythropoietin und Eisenpräparate
ATE281155T1 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
TR199903197T2 (xx) Uyku apnea sendromunun tedavisinde yararl� ila�lar�n haz�rlanmas� i�in �zel bir 5HT2 resept�r antagonistinin kullan�lmas�.
GB0016189D0 (en) Cosmetic composition
TR200102265T2 (tr) Anestezi düzenlemesi.
ATE271852T1 (de) Verbesserte inhalationspräparate
ATE504309T1 (de) Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis
DE50114335D1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
TR200401810T4 (tr) Kısırlık tedavisinde fsh'ın kullanılması